Courtesy of Dr. José Álvarez. The RESPECT trial is a multicenter randomized trial with blinded adjudication of end-point events. It randomly assigned patients from 18 to 60 years of age who had a patent foramen ovale (PFO) and a history of cryptogenic ischemic stroke to undergo closure of the PFO with the Amplatzer device plus medical...
SYNTAX II: Better Stents, IVUS, FFR, or a Combination of All of Them to Catch Up with Surgery
In patients with 3-vessel disease, surgery obtained better outcomes than angioplasty, according to results from the SYNTAX and FREEDOM trials, which used first-generation drug-eluting stents. Even in the BEST trial, which used new-generation stents, surgery still offered far better outcomes. Nobody is surprised by the fact that, whenever angioplasty evolves due to a new device...
DETO2X-AMI: Supplemental O2 Provides No Benefit for Patients with Suspected Infarction
According to this study simultaneously presented at the European Society of Cardiology Congress 2017 and published in the New England Journal of Medicine, routinely providing supplemental oxygen therapy to patients without hypoxemia with suspected acute myocardial infarction did not result in a reduction in the 1-year risk of all-cause mortality when compared with patients receiving...
Take a look at the Colombia Sessions 2017 Program
You can view the program of the Colombia Sessions 2017, to be held on October 05 and 06 in Bogotá, Colombia. (Spanish version). At the same time, you can check the Nurses & Technicians program of the Colombia Sessions (Spanish version).
Minimum Appropriate Follow-Up Reduces Mortality After Endoprosthesis Implantation
No study has been able to prove long-term benefit of regular imaging follow-up after abdominal aortic aneurysm repair by means of endoprosthesis implantation. This is important because the costs for these studies are high, which should be added to potential radiation and contrast morbidity. This work sought to characterize the association between post-endovascular abdominal aortic aneurysm...
Polymer-Free DES Also Show Efficacy in Anticoagulated Patients with High Risk for Bleeding
Patients who receive chronic anticoagulation therapy and then undergo angioplasty are frequently discharged on a triple anti-thrombotic scheme that usually includes aspirin, clopidogrel, and warfarin. The optimal duration of this indication remains unclear, particularly for patients at high bleeding risk. According to expert consensus, patients receiving chronic anticoagulation may receive from 1 to 12 months of dual...
Pacemaker Implantation After TAVI Raises Costs But Not the Incidence of Adverse Events
This new meta-analysis did not manage to prove whether permanent pacemaker implantation after transcatheter aortic valve replacement (TAVR) raises the rates of mortality, infarction, or stroke. Implantation could only be associated to a lesser recovery of ventricular function after the procedure, something that had already been observed in previous studies. Patients who required a pacemaker undoubtedly...
All you need to know about Nicaragua Sessions 2017
For the first time since the Regional Sessions first took place, SOLACI is landing in Managua (Nicaragua) to hold an event of paramount scientific value for Latin American interventional cardiology. The aim of this Sessions is, on one hand, to strengthen SOLACI’s ties with the region and, on the other hand, to promote the specialty’s...
All you need to know about Colombia Sessions 2017
After 3 long years, SOLACI is coming back to Colombia to celebrate the 14th Regional Sessions in an unmissable event to continue to strengthen interventional cardiology in all Latin America. The meeting will take place in Bogota, on October 5 and 6, 2017. Are you planning on participating of the next Colombia Sessions 2017? Here...
VALIDATE-SWEDEHEART: bivalirudin seems to be losing ground
Another important work that does not see the benefits of bivalirudin over heparin as monotherapy as regards both efficacy (death and MI) and safety end points (bleeding) in patients undergoing acute myocardial infarction with and without ST elevation. The study VALIDATE-SWEDEHEART, presented at ESC, simultaneously published in the New England Journal of Medicine, randomized 6000 patients...